xMAP Verigene II, New Assay Launches Anticipated to Revivify Luminex Revenues in 2020 Premium The firm said that its Verigene II multiplex system is on track to launch in mid-2020 among a number of new products scheduled for release this year. Luminex Q4 Revenues Rise 12 Percent The firm submitted its Verigene II Gastrointestinal Flex Assay to the FDA in Q4 and expects to submit Verigene II Respiratory Flex Assay to the agency in Q1 2020. Protagen, Qiagen Collaborate to Advance Development of Protein-based CDx for Autoimmune Diseases Protagen announced a long-term collaboration agreement with Qiagen to provide pharmaceutical partners access to technology that would advance the development of protein-based companion tests for autoimmune disorders. Luminex Q3 Revenues Jump 12 Percent on Assay Sales NEW YORK (GenomeWeb) — Luminex reported after the close of the market Monday a 12 percent spike in third quarter revenues driven primarily by growth in assay sales across all major product categories. Federal Court Dismisses IP Infringement Claims Against Luminex NEW YORK (GenomeWeb News) – A federal court has dismissed claims against Luminex that had alleged patent infringement. Nov 4, 2013 Irori Sues Luminex for Patent Infringement Sep 17, 2013 Luminex CEO Discusses M&A Strategy, Divestiture as Firm Focuses on Existing MDx Developments Premium Aug 13, 2013 Luminex Divests Newborn Screening Group Citing 'Unpredictable, Burdensome' US Regulatory Process Premium Jun 18, 2013 NMTC's 'Italian Soap Opera' Leaves Luminex Crowing 'Nice Win' While GenMark Cuts Guidance Premium Jun 12, 2013 MDx/CDx Focus: Exact Finishes Cologuard Submission; Natural Molecular Launches Cardiac Test on xMAP Premium Jun 11, 2013 Luminex, Natural Molecular Testing Team Up on Personalized Medicine Panel, Causing GenMark Shares to Plummet May 16, 2013 Luminex Leveraging Advanced Liquid Logic Alliance to Develop Field-based MDx/Immunoassay System Premium Apr 16, 2013 Luminex to Target Smaller Clinical Labs with FDA-Cleared MagPix System, Gastro Pathogen Panel Premium Apr 2, 2013 Affymetrix's eBio Business Moving FlowCytomix Assays to Luminex Platform, Planning New Product Combinations Premium Mar 20, 2013 Merck Taps Luminex to Develop CDx to Stratify Patients for Alzheimer's Drug Trials Premium Feb 5, 2013 Luminex's 2013 Priorities Include GPP, NeoPlex Adoption, MagPix Placements, Project Aries Premium Jan 15, 2013 UPDATE: Luminex Gains FDA Clearance for Gastro Test; Expects Clearance for Newborn Test in H2 Premium Dec 13, 2012 Luminex Combining EraGen, GenturaDx Techs to Reach HT, Lower-Plex, and LDT Markets Premium Nov 2, 2012 Luminex Provides Update on GenturaDx Integration, MDx Pipeline Activities amid Q3 Earnings Premium Oct 30, 2012 Luminex Expects 2013 FDA Clearance for Gastro Pathogen Panel as Q3 Revenues Rise 10 Percent Premium Oct 30, 2012 Q&A: SciLifeLab's Peter Nilsson Relies on 'Unique Array Set Up' to Screen the Human Protein Atlas Premium Jul 12, 2012 Luminex Looks to Target Mid- to Low-Volume MDx Labs with GenturaDx Platform Premium Apr 3, 2012 Luminex, Bio-Rad Extend Deal, Includes Magpix System Aug 23, 2011 NYU Researchers Win $368K NIH Grant to Study Race and Prostate Cancer Premium Aug 17, 2011 Advanced Liquid Logic Wins SBIR Grant to Develop Biobanking QC Product Premium Load More Breaking News Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates Veracyte Q2 Revenues More Than Double on Test Volume Spike Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent Qiagen Q2 Revenues Grow 28 Percent CareDx Q2 Revenues Up 77 Percent Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds The Scan Booster Push New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high. With Help from Mr. Fluffington, PurrhD Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic. Man Charged With Threatening to Harm Fauci, Collins The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials. Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.